Lopatin Iu M
Kardiologiia. 2010;50(1):78-83.
The article is devoted to results of additional analysis of a randomized, double-blind, placebo-controlled, parallel-group BEAUTIFUL trial. Effects of If inhibitor ivabradine in patients with ischemic heart disease, left ventricular dysfunction and stable angina were analyzed.
本文致力于对一项随机、双盲、安慰剂对照、平行组BEAUTIFUL试验进行额外分析的结果。分析了If抑制剂伊伐布雷定对缺血性心脏病、左心室功能障碍和稳定型心绞痛患者的影响。